Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
Holding SNSE?
Track your performance easily

Sensei Biotherapeutics (SNSE) Income Statement

180 Followers

Sensei Biotherapeutics Income Statement

Last quarter (Q2 2024), Sensei Biotherapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Sensei Biotherapeutics's net income was $-7.14M. See Sensei Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 370.00K$ 331.00K--$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 370.00K$ 331.00K----
Operating Expense
$ 32.40M$ 37.06M$ 50.19M$ 37.48M$ 18.71M$ 12.44M
Operating Income
$ -32.40M$ -37.06M$ -50.19M$ -37.48M$ -18.71M$ -12.44M
Net Non Operating Interest Income Expense
$ -116.00K$ -3.48M$ -1.56M$ -670.00K$ -1.69M$ -2.26M
Other Income Expense
$ -2.84M$ -517.00K$ 36.00K$ -1.36M$ 302.00K$ -2.05M
Pretax Income
$ 1.66M$ -34.10M$ -48.59M$ 6.53M$ -20.10M$ -16.74M
Tax Provision
$ -9.89M$ -9.89M$ -10.35M$ -8.30M--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -29.67M$ -34.10M$ -48.59M$ -36.79M$ -20.20M$ -20.54M
Basic EPS
$ -1.18$ -1.22$ -1.58$ -1.33$ -0.68$ -29.98
Diluted EPS
$ -1.18$ -1.22$ -1.58$ -1.33$ -0.68$ -29.98
Basic Average Shares
$ 100.59M$ 27.95M$ 30.70M$ 27.71M$ 29.56M$ 685.16K
Diluted Average Shares
$ 100.59M$ 27.95M$ 30.70M-$ 29.56M$ 685.16K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 30.30M$ 37.06M$ 50.19M$ 37.48M$ 18.71M$ 12.44M
Net Income From Continuing And Discontinued Operation
$ -29.67M$ -34.10M$ -48.59M$ -36.79M$ -20.10M$ -16.74M
Normalized Income
$ -5.17M--$ -1.77M$ -20.40M$ -14.69M
Interest Expense
----$ 1.69M$ 2.26M
EBIT
$ -17.26M$ -33.96M$ -48.37M$ 7.20M$ -18.41M$ -14.48M
EBITDA
$ -15.51M$ -32.61M$ -47.02M$ 7.88M$ -18.20M$ -14.41M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis